The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Sirtuins in mammals: insights into their biological function
Michan, S., & Sinclair, D. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,718
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.026 · Cited by 1,487
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Trinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,368
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Self-citationRecovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153 · cited 1×
“Notably, it has been shown that HDAC6 regulates the activity of the chaperone heat shock protein 90 (HSP90), which provides an additional mechanistic insight into the role of this deacetylase in protein degradatio”
BackgroundSIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., et al. (2008) · Nature · doi:10.1038/nature06736 · Cited by 1,111 · cited 1×
“Finally, SIRT6 has recently been shown to be involved in the regulation of telomomeric DNA during S phase where the putative enzymatic target is K9 on H3 (Ref”
BackgroundZhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,062
Self-citationSirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J.-C., McLean, P. J., et al. (2007) · Science · doi:10.1126/science.1143780 · Cited by 1,062
Self-citationCalorie restriction, SIRT1 and metabolism: understanding longevity
Bordone, L., & Guarente, L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1616 · Cited by 1,020
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979
Microglial Activation and its Implications in the Brain Diseases
Thameem Dheen, S., Kaur, C., & Ling, E.-A. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 952
Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression
Laherty, C. D., Yang, W.-M., Sun, J.-M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997) · Cell · doi:10.1016/s0092-8674(00)80215-9 · Cited by 938
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.031 · Cited by 916
Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice
Alarcón, J. M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E. R., & Barco, A. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.021 · Cited by 892
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Self-citationVecsey, C. G., Hawk, J. D., Lattal, K. M., Stein, J. M., Fabian, S. A., Attner, M. A., Cabrera, S. M., McDonough, C. B., Brindle, P. K., Abel, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0296-07.2007 · Cited by 831
Calorie restriction–the SIR2 connection
Guarente, L., & Picard, F. (2005) · Cell · doi:10.1016/j.cell.2005.01.029 · Cited by 793
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
Hallows, W. C., Lee, S., & Denu, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604392103 · Cited by 792
Dompierre, J. P., Godin, J. D., Charrin, B. C., Cordelières, F. P., King, S. J., Humbert, S., & Saudou, F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0037-07.2007 · Cited by 792
Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., & Horio, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609554200 · Cited by 765
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111871200 · Cited by 744
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., & Matthias, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg115 · Cited by 740 · cited 1×
“In addition to modification of histones, other (non-histone) cellular proteins are substrates for HDACs, and these proteins mediate diverse biological functions via transcriptional-dependent as well as independent mechanism”
BackgroundSIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
SIRT1 transgenic mice show phenotypes resembling calorie restriction
Bordone, L., Cohen, D., Robinson, A., Motta, M. C., Van Veen, E., Czopik, A., Steele, A. D., Crowe, H., Marmor, S., Luo, J., et al. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00335.x · Cited by 722
In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation
Matsuyama, A., Shimazu, T., Sumida, Y., Saito, A., Yoshimatsu, Y., Seigneurin‐Berny, D., Osada, H., Komatsu, Y., Nishino, N., Khochbin, S., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf682 · Cited by 720
HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.
Iwata, A., Riley, B. E., Johnston, J. A., & Kopito, R. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508786200 · Cited by 719
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713
Schwer, B., Bunkenborg, J., Verdin, R. O., Andersen, J. S., & Verdin, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603968103 · Cited by 705
Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
Covalent modifications of histones during development and disease pathogenesis
Bhaumik, S. R., Smith, E., & Shilatifard, A. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1337 · Cited by 681
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H.-L., Alt, F. W., Serrano, L., Sternglanz, R., & Reinberg, D. (2006) · Genes & Development · doi:10.1101/gad.1412706 · Cited by 665
Identification of genes that modify ataxin-1-induced neurodegeneration
Fernandez-Funez, P., Nino-Rosales, M. L., de Gouyon, B., She, W.-C., Luchak, J. M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P. J., et al. (2000) · Nature · doi:10.1038/35040584 · Cited by 661
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
SIRT1 Deacetylates and Positively Regulates the Nuclear Receptor LXR
Li, X., Zhang, S., Blander, G., Tse, J. G., Krieger, M., & Guarente, L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.032 · Cited by 634
Nakamura, K. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1441 · Cited by 623
Schwer, B., North, B. J., Frye, R. A., Ott, M., & Verdin, E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205057 · Cited by 598
Grozinger, C. M., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140199597 · Cited by 588
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Toward a unified theory of caloric restriction and longevity regulation
Sinclair, D. A. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.03.019 · Cited by 563
Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559 · cited 1×
“Furthermore, Hdac6 -knockout mice have hyperacetylated tubulin, are viable and develop normally, lacking any apparent neurological abnormalitie”
BackgroundKim, H. J., Rowe, M., Ren, M., Hong, J.-S., Chen, P.-S., & Chuang, D.-M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 557
Lu, J., McKinsey, T. A., Zhang, C.-L., & Olson, E. N. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00025-3 · Cited by 547
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541
Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., & Schreiber, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106779200 · Cited by 539
Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1
Napper, A. D., Hixon, J., McDonagh, T., Keavey, K., Pons, J.-F., Barker, J., Yau, W. T., Amouzegh, P., Flegg, A., Hamelin, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050522v · Cited by 523
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2
Mao, Z., Bonni, A., Xia, F., Nadal-Vicens, M., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5440.785 · Cited by 506
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
ABEL, T., & ZUKIN, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.002 · Cited by 494
A Decade of Molecular Studies of Fragile X Syndrome
O'Donnell, W. T., & Warren, S. T. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142909 · Cited by 481
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., & Gottesfeld, J. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio815 · Cited by 442
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L., & Reinberg, D. (2007) · Nature · doi:10.1038/nature06268 · Cited by 439
Autophagy and Its Possible Roles in Nervous System Diseases, Damage and Repair
Rubinsztein, D. C., DiFiglia, M., Heintz, N., Nixon, R. A., Qin, Z.-H., Ravikumar, B., Stefanis, L., & Tolkovsky, A. (2005) · Autophagy · doi:10.4161/auto.1.1.1513 · Cited by 423
Genetic links between diet and lifespan: shared mechanisms from yeast to humans
Bishop, N. A., & Guarente, L. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2188 · Cited by 423
Huntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404
Self-citationRen, M., Leng, Y., Jeong, M., Leeds, P. R., & Chuang, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02406.x · Cited by 378
The histone deacetylase-3 complex contains nuclear receptor corepressors
Wen, Y.-D., Perissi, V., Staszewski, L. M., Yang, W.-M., Krones, A., Glass, C. K., Rosenfeld, M. G., & Seto, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7202 · Cited by 378
Guarente, L. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.024 · Cited by 371
Ryu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., Dangond, F., Cormier, K. A., Cudkowicz, M. E., H. Brown, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03077.x · Cited by 353
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Avila, A. M., Burnett, B. G., Taye, A. A., Gabanella, F., Knight, M. A., Hartenstein, P., Cizman, Z., Di Prospero, N. A., Pellizzoni, L., Fischbeck, K. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29562 · Cited by 350
HDAC inhibitors: Clinical update and mechanism-based potential
Glaser, K. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.007 · Cited by 348
Distribution of histone deacetylases 1–11 in the rat brain
Broide, R. S., Redwine, J. M., Aftahi, N., Young, W., Bloom, F. E., & Winrow, C. J. (2007) · Journal of Molecular Neuroscience · doi:10.1007/bf02686117 · Cited by 347
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons
Li, Y., Xu, W., McBurney, M. W., & Longo, V. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.004 · Cited by 331
The Sir2 family of protein deacetylases
Denu, J. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.08.010 · Cited by 325
Oike, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.387 · Cited by 305
Neuronal activity‐dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5
Chawla, S., Vanhoutte, P., Arnold, F. J. L., Huang, C. L. ‐., & Bading, H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01648.x · Cited by 300
Polyglutamine diseases: emerging concepts in pathogenesis and therapy
Shao, J., & Diamond, M. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm213 · Cited by 287
Class II histone deacetylases: Structure, function, and regulation
Bertos, N. R., Wang, A. H., & Yang, X.-J. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-243 · Cited by 276
Camelo, S., Iglesias, A. H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S. G., Imitola, J., Duran, G., Assaf, B., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.022 · Cited by 275
The Sirtuin family: therapeutic targets to treat diseases of aging
Milne, J. C., & Denu, J. M. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.019 · Cited by 271
SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes
Berdeaux, R., Goebel, N., Banaszynski, L., Takemori, H., Wandless, T., Shelton, G. D., & Montminy, M. (2007) · Nature Medicine · doi:10.1038/nm1573 · Cited by 266
Pallos, J., Bodai, L., Lukacsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., & Marsh, J. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn273 · Cited by 265
Self-citationLi, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., Guo, J., Ling, E.-A., & Liang, F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4181-06.2007 · Cited by 265
Minamiyama, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh131 · Cited by 260
Freiman, R. N., & Tjian, R. (2003) · Cell · doi:10.1016/s0092-8674(02)01278-3 · Cited by 259
Faraco, G., Pancani, T., Formentini, L., Mascagni, P., Fossati, G., Leoni, F., Moroni, F., & Chiarugi, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027912 · Cited by 255
Functional Domains of Histone Deacetylase-3
Yang, W.-M., Tsai, S.-C., Wen, Y.-D., Fejér, G., & Seto, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105993200 · Cited by 248
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7302-7312.2002 · Cited by 246
Class IIa histone deacetylases: regulating the regulators
Martin, M., Kettmann, R., & Dequiedt, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210613 · Cited by 244
Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes
Helmlinger, D. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh139 · Cited by 242
Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo
Fischle, W., Dequiedt, F., Fillion, M., Hendzel, M. J., Voelter, W., & Verdin, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104935200 · Cited by 232
Simonini, M. V., Camargo, L. M., Dong, E., Maloku, E., Veldic, M., Costa, E., & Guidotti, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510341103 · Cited by 229
Mechanism for Nucleocytoplasmic Shuttling of Histone Deacetylase 7
Kao, H.-Y., Verdel, A., Tsai, C.-C., Simon, C., Juguilon, H., & Khochbin, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107631200 · Cited by 223
Zhang, C. L., McKinsey, T. A., Lu, J.-R., & Olson, E. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007364200 · Cited by 220
Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
Rai, M., Soragni, E., Jenssen, K., Burnett, R., Herman, D., Coppola, G., Geschwind, D. H., Gottesfeld, J. M., & Pandolfo, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001958 · Cited by 214
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
Butler, R., & Bates, G. P. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1989 · Cited by 214
Inhibitors of Histone Deacetylase as New Anticancer Agents
Jung, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372058 · Cited by 213
Rouaux, C., Panteleeva, I., René, F., Gonzalez de Aguilar, J.-L., Echaniz-Laguna, A., Dupuis, L., Menger, Y., Boutillier, A.-L., & Loeffler, J.-P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1139-07.2007 · Cited by 213
Luthi-Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1927 · Cited by 211
Kruhlak, M. J., Hendzel, M. J., Fischle, W., Bertos, N. R., Hameed, S., Yang, X.-J., Verdin, E., & Bazett-Jones, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100290200 · Cited by 207
Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2
Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., & Yang, X.-J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-06 · Cited by 203
Haggarty, S. J., Koeller, K. M., Wong, J. C., Butcher, R. A., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00095-4 · Cited by 201
The Antiapoptotic Actions of Mood Stabilizers: Molecular Mechanisms and Therapeutic Potentials
CHUANG, D.-M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1344.018 · Cited by 196
Multiple Sclerosis: Immune System Molecule Expression in the Central Nervous System
Raine, C. S. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199407000-00002 · Cited by 195
Trapp, J., Meier, R., Hongwiset, D., Kassack, M. U., Sippl, W., & Jung, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700003 · Cited by 193
Beckers, T., Burkhardt, C., Wieland, H., Gimmnich, P., Ciossek, T., Maier, T., & Sanders, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22751 · Cited by 192
Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death
Bolger, T. A., & Yao, T.-P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1826-05.2005 · Cited by 191
Lipid and cholesterol trafficking in NPC
Mukherjee, S., & Maxfield, F. R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.009 · Cited by 190
SIR2: a potential target for calorie restriction mimetics
Chen, D., & Guarente, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.004 · Cited by 185
Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals
Wang, A. H., & Yang, X.-J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5992-6005.2001 · Cited by 183
Tong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Sakamoto, J., Miura, T., Shimamoto, K., & Horio, Y. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01444-3 · Cited by 179
Berke, S. J. S., & Paulson, H. L. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00053-4 · Cited by 178
Serra, H. G., Byam, C. E., Lande, J. D., Tousey, S. K., Zoghbi, H. Y., & Orr, H. T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh268 · Cited by 176
Paths of Convergence: Sirtuins in Aging and Neurodegeneration
Gan, L., & Mucke, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.015 · Cited by 172
Mai, A., Massa, S., Lavu, S., Pezzi, R., Simeoni, S., Ragno, R., Mariotti, F. R., Chiani, F., Camilloni, G., & Sinclair, D. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050100l · Cited by 169
Langley, B., Gensert, J., Beal, M., & Ratan, R. (2005) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007053005091 · Cited by 168
Hess‐Stumpp, H., Bracker, T. U., Henderson, D. A., & Politz, O. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.009 · Cited by 165
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders
Hahnen, E., Hauke, J., Tränkle, C., Eyüpoglu, I. Y., Wirth, B., & Blümcke, I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.169 · Cited by 165
Murphy, P. J. M., Morishima, Y., Kovacs, J. J., Yao, T.-P., & Pratt, W. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506997200 · Cited by 164
The role of histone acetylation in SMN gene expression
Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., & Sumner, C. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi130 · Cited by 164
Evert, B. O., Araujo, J., Vieira-Saecker, A. M., de Vos, R. A. I., Harendza, S., Klockgether, T., & Wüllner, U. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2053-06.2006 · Cited by 162
Hahnen, E., Eyüpoglu, I. Y., Brichta, L., Haastert‐Talini, K., Tränkle, C., Siebzehnrübl, F. A., Rießland, M., Hölker, I., Claus, P., Romstöck, J., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03868.x · Cited by 157
Bates, E. A., Victor, M., Jones, A. K., Shi, Y., & Hart, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3344-05.2006 · Cited by 151
Lipid imbalance in the neurological disorder, Niemann‐Pick C disease
Vance, J. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.008 · Cited by 151
Karten, B., Vance, D. E., Campenot, R. B., & Vance, J. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01220.x · Cited by 149
Langley, B. C., D’Annibale, M. A., Suh, K., Ayoub, I. A., Tolhurst, A. T., Baştan, B., Yang, L., Ko, B., Fisher, M., Cho, S., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3200-07.2008 · Cited by 148
Transcription, translation and fragile X syndrome
Garber, K. B., Smith, K. T., Reines, D., & Warren, S. T. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.04.010 · Cited by 148
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
Petrie, K. R., Guidez, F., Howell, L., Healy, L. E., Waxman, S., Greaves, M. F., & Zelent, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212935200 · Cited by 147
Oliveira, J. M. A., Chen, S., Almeida, S., Riley, R. R., Gonçalves, J., Oliveira, C. R., Hayden, M. R., Nicholls, D. G., Ellerby, L., & Rego, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3004-06.2006 · Cited by 147
Control of histone modifications
Davie, J., & Spencer, V. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1999)75:32+<141::aid-jcb17>3.0.co;2-a · Cited by 147
Tsai, C., Kao, H., Mitzutani, A., Banayo, E., Rajan, H., McKeown, M., & Evans, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400615101 · Cited by 145
Zhang, B., West, E. J., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X.-M., Kozikowski, A. P., & Lyeth, B. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.085 · Cited by 144
Microtubule Deacetylases, SirT2 and HDAC6, in the Nervous System
Southwood, C. M., Peppi, M., Dryden, S. C., Tainsky, M. A., & Gow, A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9127-6 · Cited by 144
Niemann-Pick Type C Disease and Alzheimer's Disease
Nixon, R. A. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63163-x · Cited by 142
Therapeutic role of sirtuins in neurodegenerative disease
Outeiro, T. F., Marques, O., & Kazantsev, A. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.02.010 · Cited by 139
Self-citationTrushina, E., Singh, R., Dyer, R. B., Cao, S., Shah, V., Parton, R., Pagano, R., & McMurray, C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl434 · Cited by 131
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131198498 · Cited by 129
Rießland, M., Brichta, L., Hahnen, E., & Wirth, B. (2006) · Human Genetics · doi:10.1007/s00439-006-0186-1 · Cited by 126
The complexity of chromatin remodeling and its links to cancer
Neely, K., & Workman, J. L. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00067-7 · Cited by 124
Histone acetylation and the cell-cycle in cancer
Wang, C., Fu, M., Mani, S., Wadler, S., Senderowicz, A. M., & Pestell, R. G. (2001) · Frontiers in bioscience · doi:10.2741/1wang1 · Cited by 121
Zhou, X., Richon, V. M., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1056 · Cited by 120
Hooper, N. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330335 · Cited by 117
Pietrobono, R., Pomponi, M. G., Tabolacci, E., Oostra, B., Chiurazzi, P., & Neri, G. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf434 · Cited by 117
Valenza, M., Leoni, V., Tarditi, A., Mariotti, C., Björkhem, I., Di Donato, S., & Cattaneo, E. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.004 · Cited by 115
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Valenza, M., Carroll, J. B., Leoni, V., Bertram, L. N., Bjorkhem, I., Singaraja, R. R., Di Donato, S., Lutjohann, D., Hayden, M. R., & Cattaneo, E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm170 · Cited by 115
Environmental and dietary risk factors in Alzheimer’s disease
Dosunmu, R., Wu, J., Basha, R. M., & Zawia, N. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.887 · Cited by 114
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases
JONES, P. G., Altamura, S., Francesco, R. D., Gallinari, P., Lahm, A., Neddermann, P., Rowley, M., Serafini, S., & Steinkühler, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.025 · Cited by 114
Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons
Karten, B., Vance, D. E., Campenot, R. B., & Vance, J. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205406200 · Cited by 108
Brain-Based Devices for the Study of Nervous Systems and the Development of Intelligent Machines
Krichmar, J. L., & Edelman, G. M. (2005) · Artificial Life · doi:10.1162/1064546053278946 · Cited by 106
Lü, Q., Yang, Y., Chen, C., Davis, M. E., Byrd, J. C., Etherton, M. R., Umar, A., & Chen, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303655 · Cited by 105
Neuroprotection by histone deacetylase-related protein
Morrison, B. E., Majdzadeh, N., Zhang, X., Lyles, A., Bassel-Duby, R., Olson, E. N., & D'Mello, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3550-3564.2006 · Cited by 100
Genes and the Environment in Neurodegeneration
Coppedè, F., Mancuso, M., Siciliano, G., Migliore, L., & Murri, L. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9028-6 · Cited by 100
Type C Niemann-Pick Disease: Use of Hydrophobic Amines to Study Defective Cholesterol Transport
Roff, C. F., Goldin, E., Comly, M. E., Cooney, A. M., Brown, A., Vanier, M. T., Miller, S. P. F., Brady, R. O., & Pentchev, P. G. (1991) · Developmental Neuroscience · doi:10.1159/000112179 · Cited by 99
Gray, S. G., & Dangond, F. (2006) · Epigenetics · doi:10.4161/epi.1.2.2678 · Cited by 99
Giorgini, F., Möller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S. Y., Tsai, L. L., Cheah, C. S., Schwarcz, R. M., Guidetti, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708192200 · Cited by 98
The genetics of neurodegenerative diseases
Hardy, J., & Orr, H. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03979.x · Cited by 94
Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B. A., Chiurazzi, P., & Neri, G. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201393 · Cited by 92
A work in progress: The clinical development of histone deacetylase inhibitor
Marsoni, S., Damia, G. L. M., & Camboni, G. (2008) · Epigenetics · doi:10.4161/epi.3.3.6253 · Cited by 91
Arts, J., Angibaud, P. R., Mariën, A., Floren, W., Janssens, B., King, P., Dun, J. V., Janssen, L., Geerts, T., Tuman, R. W., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604025 · Cited by 89
Developmental expression of histone deacetylase 11 in the murine brain
Liu, H., Hu, Q., Kaufman, A. R., D’Ercole, A. J., & Ye, P. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21521 · Cited by 88
Garver, W. S., & Heidenreich, R. A. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362375 · Cited by 85
Histone deacetylases: Focus on the nervous system
Morrison, B. E., Majdzadeh, N., & D’Mello, S. R. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7035-9 · Cited by 84
Marcotte, P. A., Richardson, P. R., Guo, J., Barrett, L. W., Xu, N., Gunasekera, A. H., & Glaser, K. B. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.039 · Cited by 83
SIRT1 Inhibition Alleviates Gene Silencing in Fragile X Mental Retardation Syndrome
Biacsi, R. E., Kumari, D., & Usdin, K. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000017 · Cited by 83
Senawong, T., Peterson, V. J., & Leid, M. E. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.028 · Cited by 78
Histone Deacetylase Inhibitors: The Abbott Experience
Curtin, M. L., & Glaser, K. B. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456576 · Cited by 78
Sadri‐Vakili, G., & Cha, J.-H. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249407 · Cited by 71
HDAC inhibitors for the treatment of cancer.
Secrist, J. P., Zhou, X., & Richon, V. M. (2003) · PubMed · Cited by 68
Kim, S.-J., Lee, B., Lee, Y.-S., & Kang, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.116 · Cited by 67
Differential protein acetylation induced by novel histone deacetylase inhibitors
Glaser, K. B., Li, J., Pease, L. J., Staver, M. J., Marcotte, P. A., Guo, J., Frey, R. R., Garland, R. B., Heyman, H. R., Wada, C. K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.082 · Cited by 67
Belfield, J. L., Whittaker, C., Cader, M. Z., & Chawla, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601485200 · Cited by 66
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1
Catoire, H., Pasco, M. Y., Abu‐Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G. A., Parker, J. A., & Néri, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn109 · Cited by 65
Transcriptional alterations and chromatin remodeling in polyglutamine diseases
Helmlinger, D., Tora, L., & Devys, D. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.07.010 · Cited by 63
Mai, A., Massa, S., Pezzi, R., Rotili, D., Loidl, P., & Brosch, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034167p · Cited by 60
Brain Drug Development and Brain Drug Targeting
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9387-0 · Cited by 59
Bispyridinium Dienes: Histone Deacetylase Inhibitors with Selective Activities
Pérez‐Balado, C., Nebbioso, A., Rodríguez‐Graña, P., Minichiello, A., Miceli, M., Altucci, L., & de Lera, Á. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070028m · Cited by 53
Research works printed but not linked: 5
- Gallen, C. C. Strategic challenges in neurotherapeutic pharmaceutical development. NeuroRx 1, 165–180 (2004). · doi:10.1602/neurorx.1.1.165
- Thomas, E. A. et al. The histone deacetylase inhibitor, HDACi 4b, ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc. Natl Acad. Sci. USA (in the press).
- Mai, A. et al. Synthesis and biological evaluation of 2-, 3-, and 4-acylaminocinnamyl-N-hydroxyamides as novel synthetic HDAC inhibitors. Med. Chem. 1, 245–254 (2005). · doi:10.2174/1573406053765431
- Khan, N. et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. 409, 581–589 (2008). · DOI · Paper page
- Galletti, P. et al. Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol. Dial. Transplant. 20, 1551–1558 (2005). · doi:10.1093/ndt/gfh846
Cited by
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Chemistry and Biology Of Multicomponent Reactions
Dömling, A., Wang, W., & Wang, K. (2012) · Chemical Reviews · doi:10.1021/cr100233r · Cited by 2,547
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes
Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., & Zhao, K. (2009) · Cell · doi:10.1016/j.cell.2009.06.049 · Cited by 1,344
“However, the drug development community faces significant challenges in the selection and design of drugs for clinical candidates, partially because of the lack of known targets of HATs and HDACs (Kazantsev and Thompson, 2008).”
BackgroundTargeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,243
Metadata
- Authors
- Kazantsev, A. G., & Thompson, L. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-10
- Volume
- 7
- Issue
- 10
- Pages
- 854-868
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1996277745
- Cited by
- 711
- References
- 216
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.